Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[Clinical guidelines for diagnosing, treatment and monitoring patients with prostate cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association].

Solarić M, Grgić M, Omrcen T, Petković M, Fröbe A, Belaj N, Zorica R, Kruslin B, Dordević G, Kastelan Z, Ruzić B, Gilja I, Krolo I, Vilović K, Librenjak D, Vrdoljak E, Situm M, Padovan RS, Vojnović Z; Croatian Medical Association.

Lijec Vjesn. 2013 Nov-Dec;135(11-12):298-305. Croatian.

PMID:
24490329
2.

[Clinical guidelines for diagnosing, treatment and monitoring patients with testicular cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association].

Grgić M, Bolanca A, Ledina D, Gugić D, Solarić M, Omrcen T, Zorica R, Galić J, Trnski D, Pasini J, Padovan RS, Petkovic M, Balenović A, Juretić A, Kastelan Z, Gamulin M; Croatian Medical Association.

Lijec Vjesn. 2013 Nov-Dec;135(11-12):287-91. Croatian.

PMID:
24490327
3.

[Clinical recommendations for diagnosing, treatment and monitoring of patients with uterine cervical cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].

Vrdoljak E, Haller H, Corusić A, Jelavić TB, Matković V, Strinić T, Karnjus-Begonja R, Barisić D, Tomić S, Babić D, Kukura V, Mise BP, Padovan RS, Matić M, Puljiz M, Krasević M, Fröbe A, Topolovec Z, Hajredini A, Vrdoljak-Mozetic D, Mamula O, Bolanca IK, Brnić-Fischer A; Croatian Oncology Society; Croatian Society for Gynecology and Obstetrics as Croatian Medical Association Units; Croatian Society of Gynecological Oncology.

Lijec Vjesn. 2013 Sep-Nov;135(9-10):225-9. Croatian.

PMID:
24364197
4.

[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].

Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.

Actas Urol Esp. 2011 Nov-Dec;35(10):565-79. doi: 10.1016/j.acuro.2011.03.011. Epub 2011 Jul 14. Spanish.

PMID:
21757258
5.

[Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].

Matković V, Haller H, Vrdoljak E, Corusić A, Jelavić TB, Strinić T, Karnjus-Begonja R, Barisic D, Tomić S, Kukura V, Ban M, Ranka SP, Matic M, Skalec SL, Topolovec Z, Mrcela M, Zekan J, Fröbe A, Hajredini A, Babic D, Mamula O, Brncić-Fischer A, Vojnović Z, Sundov D; Croatian Oncology Society; Croatian Society for Gynecology and Obstetrics as Croatian Medical Association Units; Croatian Society of Gynecological Oncology.

Lijec Vjesn. 2013 Sep-Nov;135(9-10):235-41. Croatian.

PMID:
24364199
6.

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.

Eur Urol. 2011 Apr;59(4):572-83. doi: 10.1016/j.eururo.2011.01.025. Epub 2011 Jan 25.

PMID:
21315502
7.

[Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association].

Gamulin M, Ruzić IP, Grgić M, Jazvić M, Solarić M, Zahirović D, Zorica R, Omrcen T, Petković M, Matić M, Fuckar Z, Ruzić B, Pasini J, Situm M, Dordević G, Miletić D, Tadić T, Kastelan Z, Librenjak D, Gilja I, Vilović K, Kruslin B, Kuvezdić H; Croatian Medical Association.

Lijec Vjesn. 2013 Nov-Dec;135(11-12):292-7. Croatian.

PMID:
24490328
8.

[Clinical recommendations for diagnosing, treatment and monitoring of patients with endometrial cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].

Karnjus-Begonja R, Vrdoljak E, Corusić A, Haller H, Jelavic TB, Matković V, Strinić T, Barisić D, Tomic S, Kukura V, Ban M, Padovan RS, Skalec SL, Belaj N, Puljiz M, Ferari AM, Hajredini A, Babic D, Mahovlić V, Pajtler M; Croatian Oncology Society; Croatian Society for Gynecology and Obstetrics as Croatian Medical Association Units; Croatian Society of Gynecological Oncology.

Lijec Vjesn. 2013 Sep-Nov;135(9-10):230-4. Croatian.

PMID:
24364198
9.

[Practice guideline 'Prostate cancer: diagnosis and treatment'].

de Reijke TM, Battermann JJ, van Moorselaar RJ, de Jong IJ, Visser AP, Burgers JS.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1771-5. Review. Dutch.

PMID:
18754308
10.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A.

Lancet Oncol. 2014 Sep;15(10):1076-89. doi: 10.1016/S1470-2045(14)70328-6. Epub 2014 Aug 14.

PMID:
25130995
11.

[CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH INVASIVE BREAST CANCER--CROATIAN ONCOLOGY SOCIETY].

Šeparović R, Ban M, Silovska T, Oresković LB, Soldić Ž, Podolski P, Pleština S, Gugić D, Petković M, Jakić-Razumović J, Vojnović Z, Miše BP, Tomić S, Stanec Z, Vrdoljak DV, Drinković I, Brkljačić B, Mustać E, Utrobičić I, Vrdoljak E; CROATIAN ONCOLOGY SOCIETY.

Lijec Vjesn. 2015 May-Jun;137(5-6):143-9. Croatian.

PMID:
26380471
12.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

13.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
14.
15.

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.

PMID:
17054269
16.

Evaluation and management of the man who has failed primary curative therapy for prostate cancer.

Ornstein DK, Oh J, Herschman JD, Andriole GL.

Urol Clin North Am. 1998 Nov;25(4):591-601. Review.

PMID:
10026768
17.

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.

Kijima T, Fujii Y, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Masuda H, Kawakami S, Kihara K.

BJU Int. 2012 Oct;110(8):1149-55. doi: 10.1111/j.1464-410X.2012.10959.x. Epub 2012 Feb 28.

19.

Current management of advanced and castration resistant prostate cancer.

Gomella LG, Petrylak DP, Shayegan B.

Can J Urol. 2014 Apr;21(2 Supp 1):1-6.

20.

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E.

BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.

Supplemental Content

Support Center